INMB
Board Member
Board Member
Inmune Bio, Inc. (INMB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Mark Lowdell is recorded as Board Member at Inmune Bio, Inc. (INMB). The proxy statement of Inmune Bio, Inc. reports total compensation of $1,452,236 for Mark Lowdell in fiscal 2025, including a base salary of $66,350. Disclosed compensation is on record for 6 fiscal years. Mark Lowdell has spoken on 7 earnings calls across 1 company, most recently for Inmune Bio, Inc. on May 13, 2024.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Start not stated–present
Source not stated
Recorded roles and call appearances connecting this person to public companies.
INMB
Board Member
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Inmune Bio, Inc. (INMB) | CSO | $66,350 | $1,452,236 |
| 2024 | Inmune Bio, Inc. (INMB) | CSO | — | $1,792,412 |
| 2023 | Inmune Bio, Inc. (INMB) | CSO | — | $150,237 |
| 2022 | Inmune Bio, Inc. (INMB) | CSO | — | $904,599 |
| 2021 | Inmune Bio, Inc. (INMB) | CSO | — | $149,478 |
| 2020 | Inmune Bio, Inc. (INMB) | CSO | — | $138,204 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.